More stability ahead in the French private healthcare sector
This article was originally published in Clinica
The financial instability of the French private healthcare market should not get any worse. The French government has squeezed the private healthcare sector to its limit as part of its drive to curb overall growth in healthcare spending and to add any further pressure would threaten the viability of private healthcare in France. This is the conclusion reached by analysts at Morgan Stanley in a French hospital sector overview in its Healthcare Facilities report.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.